Literature DB >> 20819183

Living related liver transplant following bone marrow transplantation from same donor: long-term survival without immunosuppression.

E Granot1, R Loewenthal, E Jakobovich, E Gazit, E Sokal, R Reding.   

Abstract

We report long-term (seven yr) immunological tolerance in a 16-yr-old boy, to a liver allograft donated by his father following a bone marrow transplant at age 2.5 yr from the same donor. The bone marrow transplant was complicated by severe GVHD leading to liver failure and the ensuing need for a liver transplant, performed under planned avoidance of immunosuppression. At one wk post-transplant, although a liver biopsy was histologically compatible with acute rejection, favorable clinical and biochemical evolution precluded initiating immunosuppressive therapy, thus highlighting the need for caution when interpreting early histological changes so that administration of unnecessary immunosuppression can be avoided. Induction of tolerance in transplant recipients remains an elusive goal. In those patients who had received conventional bone marrow transplants and had endured the consequences of GVHD, development of macrochimerism may allow immunosuppression-free solid organ transplantation from the same donor.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20819183     DOI: 10.1111/j.1399-3046.2010.01378.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  2 in total

Review 1.  Successful treatment of severe refractory hepatic graft-versus-host disease by cadaveric liver transplant.

Authors:  Amer M Zeidan; Jocelyn L Wozney; Michael Torbenson; Karen Krok; Javier Bolaños-Meade
Journal:  Leuk Lymphoma       Date:  2013-04-30

Review 2.  Solid organ transplantation following end-organ failure in recipients of hematopoietic stem cell transplantation in children.

Authors:  Kiran Upadhyay; Richard N Fine
Journal:  Pediatr Nephrol       Date:  2013-08-16       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.